Table 3.

Comparison of cancer rates¹ in the SA², API³ & NHW⁴ population of California, 1988–2000.

		Males			Females
Cancer site	time period	SA	API	NHW	SA	API	NHW
oral cavity and pharynx	1988–1991	14.6	13.2	20.6	11	7.1	9
	1992–1994	8.3	12.9	19.5	8.2	6.8	8.2
	1995–1997	11.7	13.2	18.9	6.4	6	8.1
	1998–2000	7.7	11.8	17.7	8	6	7.2
esophagus	1988–1991	7.9	6.3	6.4	2	1.4	2.3
	1992–1994	1.9	4.8	6.8	4.1	1.2	2.1
	1995–1997	5.7	4.9	7.2	3.9	1.1	2.3
	1998–2000	4.1	3.4	7.5	6	1.4	2.3
stomach	1988–1991	16.6	24.9	12.9	4.9	15.9	5.4
	1992–1994	8.6	24.9	11.4	7.6	15.5	4.6
	1995–1997	11.8	24.2	11	9.8	13.8	4.4
	1998–2000	10.8	20.5	9.7	10	12.2	4.4
liver and intrahepatic bile duct	1988–1991	10.4	21.6	4.2	5	7.2	1.9
	1992–1994	11	22.6	5	4.3	9.2	2.1
	1995–1997	9.8	24.4	5.6	5.3	9.1	2.3
	1998–2000	10.4	24.5	6.3	6.4	8.5	2.5
gall bladder	1988–1991	1	1.6	0.8	9.4	3.3	1.2
	1992–1994	1.9	1.6	0.7	9.1	2.4	1.1
	1995–1997	2.4	1.5	0.6	3.2	2.2	1.1
	1998–2000	1.2	1.2	0.6	3.6	1.8	1.1
pancreas	1988–1991	6.3	12.4	13.3	6.6	8.6	10.2
	1992–1994	4.4	11	12.8	7.3	6.6	9.9
	1995–1997	7.4	9.6	12.5	6.9	7.9	9.4
	1998–2000	10.6	8.9	11.8	3.2	7.5	9.5
lung and bronchus	1988–1991	33.5	65.3	101.9	19	28.3	59.3
	1992–1994	26.8	64.7	92.6	21.7	26.9	59.5
	1995–1997	18.5	60.8	86.5	18	28.4	60
	1998–2000	35.2	59	79	27	27.3	57.2
colon and rectum	1988–1991	42.6	57	78.8	24.6	41.9	54.6
	1992–1994	36.8	58.5	71.4	21.5	39.6	49.3
	1995–1997	46.2	58.3	67.7	24.6	39.1	47.9
	1998–2000	35.6	52.4	64.1	34.5	40.1	46.7
brain and other CNS (central nervous system)	1988–1991	8.2	4	9.4	7.4	3.6	6.5
	1992–1994	10.5	4.7	9.1	5.7	3.7	6.4
	1995–1997	3.7	3.8	8.9	3.9	3.3	6.1
	1998–2000	7.3	4	8.8	8.3	2.6	6.1
urinary bladder	1988–1991	22.3	15	43.5	5.2	4.4	10.7
	1992–1994	14.8	17	42.3	1.6	4.3	9.9
	1995–1997	18	14.8	41.2	3	4.4	10.1
	1998–2000	18.6	15.1	40.9	3.2	3.7	9.9
kidney and renal pelvis	1988–1991	8.8	6.6	14.6	2.8	3.8	6.8
	1992–1994	6.2	7	14.2	3.3	3.4	7
	1995–1997	7.9	8.3	14.8	3.2	3.9	7.3
	1998–2000	12.5	8.1	14.8	3.8	3.7	7.2
endocrine (thyroid)	1988–1991	4	4.2	4.2	7.6	9.7	7.7
	1992–1994	1.3	4.7	3.9	8.7	11.2	8
	1995–1997	2.2	4.6	4.1	9.4	11.5	8.8
	1998–2000	3.2	4.3	4.5	8.5	12.4	10.2
non-Hodgkins lymphoma	1988–1991	11	15.8	24.4	10.5	10.6	14.6
	1992–1994	13.8	16.7	25.7	16.2	10.6	14.7
	1995–1997	15.2	15.9	25.7	14.7	10.7	15.7
	1998–2000	21.1	15.7	23.3	11	11.4	15.9
Hodgkins lymphoma	1988–1991	2	1.5	3.6	1.5	0.6	2.8
	1992–1994	2.4	1.5	3.4	1.9	0.8	2.7
	1995–1997	1.7	1.2	3.4	1.5	0.8	2.8
	1998–2000	2.2	1.1	3.3	1.5	1	2.6
leukemias	1988–1991	10.4	10.9	18	9.6	6.6	10.2
	1992–1994	13.4	10.4	17.5	11.4	7	9.7
	1995–1997	9.6	9.6	16.9	9	6.3	9.8
	1998–2000	16.1	9.2	15.4	8.4	5.8	9
multiple myelomas	1988–1991	10.5	4.8	6.3	5.1	3.3	4.2
	1992–1994	5.3	4.5	6.4	7.9	2.4	3.9
	1995–1997	9.8	5.2	6.4	2.9	3.2	4.1
	1998–2000	5.6	3.7	5.7	5.5	3	3.6
skin, excluding basal & squamous cell cancer	1988–1991	8.2	3.9	44.4	2.5	2	20.5
	1992–1994	2.7	4.2	45.8	1.1	1.8	21.8
	1995–1997	4.4	3.9	50	1.9	1.6	28.3
	1998–2000	4	2.8	53.1	2.3	2.5	31.8

¹ Rates are per 100,000 and age-adjusted to the U.S. 2000 standard population (5 year age-groups).

² South Asian.

³ Asian/Pacific Islander.

⁴ white, non-Hispanic.